Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Clash of Titans: Palantir CEO and “Big Short” Investor Lock Horns Over AI Valuation

Robert Sasse by Robert Sasse
November 12, 2025
in AI & Quantum Computing, Analysis, Earnings, Nasdaq, Tech & Software
0
Palantir Stock
0
SHARES
121
VIEWS
Share on FacebookShare on Twitter

A dramatic public confrontation has erupted between Palantir Technologies CEO Alex Karp and famed investor Michael Burry, creating a stark divide in market sentiment. This clash unfolds against the backdrop of the data analytics firm reporting its strongest quarterly performance to date, placing the company’s controversial valuation squarely under the microscope.

Unprecedented Quarterly Performance

Palantir’s third-quarter earnings report silenced many skeptics, delivering results that significantly surpassed market expectations. The company generated $1.18 billion in revenue, a figure that handily beat analyst projections of $1.09 billion. This represents a staggering 63 percent year-over-year expansion.

Profitability metrics were even more compelling, with earnings per share doubling to $0.21. This result exceeded forecasts by a substantial 25 percent margin. The nearly half-billion dollars in quarterly profit marks a historic achievement for the two-decade-old firm.

A particularly noteworthy development was the explosion in Palantir’s U.S. commercial business, which surged 121 percent to $397 million. This robust growth helps alleviate long-standing concerns about the company’s previous heavy reliance on government contracts, demonstrating a successful strategic pivot toward corporate clients.

Should investors sell immediately? Or is it worth buying Palantir?

The “Rule of 40” Benchmark

CEO Alex Karp highlighted a monumental “Rule of 40” score of 114 percent, the highest in the company’s history. This key performance indicator, which combines revenue growth with operating margins, places Palantir in a league of its own when compared to sector peers. Competitors such as Snowflake, Datadog, and ServiceNow posted scores of 47 percent, 56.7 percent, and 53 percent, respectively.

A Battle of Financial Philosophies

The conflict ignited when it was revealed that Michael Burry—the investor celebrated for predicting the 2008 financial crisis—has taken a bearish position against Palantir through put options. This move aligns with a late-October social media post, his first in two years, where he cautioned about an emerging artificial intelligence bubble.

Karp responded with forceful public criticism during a November 4th CNBC appearance, describing Burry’s stance as “bats.” This direct exchange between a sitting CEO and one of the world’s most prominent short sellers represents an unusual public spectacle, with billions of dollars in market value at stake.

The Core Disagreement: Valuation

The fundamental disagreement centers on Palantir’s market valuation. Karp points to the company’s powerful fundamental business performance as justification for its stock price. Conversely, Burry perceives symptoms of overheated AI market enthusiasm that he believes echo the excesses of the dot-com era, leading him to bet against the company’s future share performance.

Ad

Palantir Stock: Buy or Sell?! New Palantir Analysis from February 7 delivers the answer:

The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Palantir: Buy or sell? Read more here...

Tags: Palantir
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Nel ASA Stock

Nel ASA Shares Surge on Landmark Hydrogen Contract

Allakos Stock

Allakos Reaches Corporate Endpoint with Concentra Acquisition

Rite Aidration Stock

Rite Aid's Final Chapter: Shareholders Face Total Wipeout

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com